|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
|
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.
|
23263592 |
2013 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was associated with a 6.4% 30-day mortality in the TURBT group compared with 0.6% in those with normal albumin (P < .0001).
|
27765612 |
2017 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Hypoalbuminemia was defined as serum albumin level <3.5 g/dl.
|
28017301 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was corrected with intravenous albumin administration.
|
28858117 |
2017 |
|
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoalbuminemia was present in 41 (25.2%) patients and serum albumin ≤3.3 g/dL represented the lowest quartile of serum albumin.
|
29604093 |
2018 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Hypoalbuminemia as assessed by the nadir albumin level was associated with an increased risk of acute worsening of renal function.
|
29865919 |
2018 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia and anemia are associated with higher mFI and independently predict poor outcome, suggesting albumin and hemoglobin are viable biomarkers of frailty in veterans.
|
31377495 |
2019 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was defined as serum albumin ≤ 2.9 g/dL.
|
31447891 |
2019 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was also associated with reduced 14-day ventilation-free days, 14-day intensive care unit (ICU)-free days, and 28-day hospital-free days.Serum albumin at admission was superior to hemoglobin in predicting the mortality in children with moderate to severe TBI and also associated with reduced ventilator-free, ICU-free, and hospital-free days.
|
31689863 |
2019 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Serum albumin was measured on admission and hypoalbuminemia was defined as total albumin ≤3.5 g/dL.
|
28283821 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Albumin is often prescribed in infants with hypoalbuminemia, hyperbilirubinemia, and protein-losing conditions.
|
28739260 |
2017 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
A total of 5143 patients met inclusion criteria; 4397 (85.5%) patients had a normal albumin level while 746 (14.5%) had hypoalbuminemia.
|
27612919 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
A total of 5779 HF patients were included in the study; mean follow-up was 576 days; median serum albumin was 4.0 g/dL (interquartile range 3.7-4.2), and 12% of the patients had hypoalbuminemia (albumin<3.5 g/dL).
|
30637771 |
2019 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
After 4 years of follow-up, Kaplan-Meier analysis showed that survival in hypoalbuminemia patients was significantly shorter than in patients with normal SA (p = 0.0393).
|
27817055 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
After adjusting for confounding factors, hypoalbuminemia was an independent predictor of in-hospital mortality in patients with either type A (HR, 2.492; 95% confidence interval [CI], 1.247-4.979; P = .010) or type B (HR, 8.729; 95% CI, 1.825-41.736; P = .007).SA is independently associated with increased in-hospital mortality in both type A and B AAD.
|
30732220 |
2019 |
|
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Although the biopsy population included primary and secondary glomerular disease patients, all 17 RVT patients had severe nephrotic syndrome and profound hypoalbuminemia with mean (SD) of albumin: 1.5 g/dL (0.66).
|
27796697 |
2017 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Anemia was defined when hemoglobin was <12 g/dL for women and <13 g/dL for men, and hypoalbuminemia when serum albumin was <3.5 g/dL.
|
28782162 |
2018 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Because preimplant hypoalbuminemia is a known risk factor for adverse outcomes, we hypothesized that change in albumin may be a prognostic indicator in patients with continuous-flow left ventricular assist devices (cfLVADs).
|
28947307 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Bivariate analyses were performed to compare the preoperative characteristics between those with normal albumin and hypoalbuminemia.
|
28187076 |
2017 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Compared to 30-day mortality with normal albumin on admission (2%), mortality was higher with mild (9%) and marked hypoalbuminemia (22%) and lower with hyperalbuminemia (0.4%).
|
31760678 |
2019 |
|
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Compared with in-hospital mortality with normal albumin on admission (2%), mortality was higher with mild (12%) and marked hypoalbuminemia (34%) and lower with hyperalbuminemia (0.3%).
|
28803138 |
2017 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Diagnostic cut-off level of Hypo-A (< 2.8 mg/dl) was determined using the ROC curve between blood albumin and mortality.
|
30729384 |
2019 |
|
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Five thousand six hundred seventy-three patients with albumin available were identified, and 29.6% had hypoalbuminemia.
|
30720559 |
2019 |
|
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Hemoglobin and albumin were significantly lower (9.72±1.9 vs. 12.2±1.8; P=.004 and 3.6±0.5 vs. 4.0±0.3; P=.035) and the proportion of patients with anemia and hypoalbuminemia was significantly higher (85.7% vs. 37.5%; P=.019 and 61.9% vs. 12.5%; P=.035) in patients with increased E/e'.
|
30032857 |
2019 |